Dopamine Hydrochloride Injection
Hospira, Inc., a Pfizer Company · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 11/06/2017
- Package NDC
- 0409-1858-12
- Generic name
- Dopamine Hydrochloride Injection
- Contact info
- 844-646-4398
- Availability
- Available
- Update date
- 09/22/2026
- Dosage form
- Injection
- Presentation
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12)
- Company name
- Hospira, Inc., a Pfizer Company
- Status
- Current
- Therapeutic category
- Cardiovascular
- Harmonized identifiers (openFDA)
- Application number
- NDA018826
- Brand name
- DOPAMINE HYDROCHLORIDE IN DEXTROSE
- Generic name
- DOPAMINE HYDROCHLORIDE IN DEXTROSE
- Manufacturer name
- Hospira, Inc.
- Product NDC
- 0409-1858, 0409-7809, 0409-7810, 0409-0042
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- DOPAMINE HYDROCHLORIDE
- RxCUI
- 1292887, 1743877, 1743879
- SPL ID
- 188ce800-ff3a-4b22-9a95-2273c3bc99ae
- SPL set ID
- 08f23f6e-150d-45ea-098e-f2edf64c21a1
- Package NDC
- 0409-7809-11, 0409-7809-22, 0409-7809-31, 0409-7809-24, 0409-7810-11, 0409-7810-22, 0409-0042-01, 0409-0042-12, 0409-1858-01, 0409-1858-12
- UNII
- 7L3E358N9L